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Precise targeting and maintenance of axonal domains in myelinated axons is essential for saltatory conduction. Caspr and Caspr2, which
localize at paranodal and juxtaparanodal domains, contain binding sites for the cytoskeletal adaptor protein 4.1B. The exact role of 4.1B
in the organization and maintenance of axonal domains is still not clear. Here, we report the generation and characterization of 4.1B-null
mice. We show that loss of 4.1B in the PNS results in mislocalization of Caspr at paranodes and destabilization of paranodal axoglial
septate junctions (AGSJs) as early as postnatal day 30. In the CNS, Caspr localization is progressively disrupted and ultrastructural
analysis showed paranodal regions that were completely devoid of AGSJs, with axolemma separated from the myelin loops, and loops
coming off the axolemma. Most importantly, our phenotypic analysis of previously generated 4.1B mutants, used in the study by Horresh
et al. (2010), showed that Caspr localization was not affected in the PNS, even after 1 year; and 4.1R was neither expressed, nor enriched
at the paranodes. Furthermore, ultrastructural analysis of these 4.1B mutants showed destabilization of CNS AGSJs at 1 year. We also
discovered that the 4.1B locus is differentially expressed in the PNS and CNS, and generates multiple splice isoforms in the PNS,
suggesting 4.1B may function differently in the PNS versus CNS. Together, our studies provide direct evidence that 4.1B plays a pivotal
role in interactions between the paranodal AGSJs and axonal cytoskeleton, and that 4.1B is critically required for long-term maintenance
of axonal domains in myelinated axons.
Introduction
A fundamental characteristic of myelinated axons is their orga-
nization into distinct molecular domains that allows for saltatory
action potential propagation. These domains include nodes,
where voltage-gated sodium channels are enriched; paranodes,
where myelin loops establish axoglial septate junctions (AGSJs)
with the axolemma; and juxtaparanodes, where delayed-rectifier
potassium channels are clustered (Bhat, 2003; Salzer, 2003; Thax-
ton and Bhat, 2009; Thaxton et al., 2011). Genetic ablation of
Caspr resulted in loss of paranodal AGSJs and disorganization of
the paranodal axonal cytoskeleton (Bhat et al., 2001; Garcia-
Fresco et al., 2006). Disruption of paranodal AGSJs in Cgt, Caspr,
Cont, and NfascNF155 mutants permitted juxtaparanodal compo-
nents to move alongside nodal sodium channels, indicating that
AGSJs serve a fence function at paranodes (Rosenbluth, 1988;
Dupree et al., 1999; Bhat et al., 2001; Boyle et al., 2001; Pillai et al.,
2009). Another member of the Caspr family, Caspr2, is required
for the organization of the juxtaparanodal domain and localiza-
tion of potassium channels (Poliak et al., 2003). The stabilization
of Caspr and Caspr2, and their associated complexes, is thought
to depend on cytoskeletal adaptor proteins that link these com-
plexes with axonal and glial cytoskeleton for their long-term
stability.
It was reported that the extracellular domain of Caspr is suf-
ficient for membrane targeting, whereas the intracellular domain
is required for Caspr stabilization at the paranodes (Gollan et al.,
2002). Both Caspr and Caspr2 contain 4.1-binding sequences,
suggesting that their interactions may be physiologically relevant
(Girault et al., 1998; Denisenko-Nehrbass et al., 2003). Several
members of the 4.1 protein family are expressed in the nervous
system (Yamakawa et al., 1999; Ohara et al., 2000; Parra et al.,
2000). Only 4.1B is enriched at paranodes and juxtaparanodes in
myelinated axons (Ohara et al., 2000; Denisenko-Nehrbass et al.,
2003). The presence of a 4.1/ezrin/radixin/moesin (FERM) and a
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spectrin-actin binding domain make 4.1B an ideal candidate to
link Caspr and Caspr2-dependent complexes with the underlying
axonal cytoskeleton. Disruption of paranodal AGSJs in Caspr and
Cont mutants alters 4.1B localization (Gollan et al., 2002; Garcia-
Fresco et al., 2006). However, Caspr2 mutants showed normal
4.1B localization (Traka et al., 2003). Recent studies showed that
loss of 4.1B does not affect paranodal Caspr localization in sciatic
nerves; and in vivo deletion of 4.1B-binding region in Caspr and
Caspr2 did not affect Caspr localization, but affected Caspr2 lo-
calization (Horresh et al., 2010).
Here, we report that 4.1B is essential for proper Caspr local-
ization and maintenance of the paranodal and juxtaparanodal
domains. We demonstrate that loss of 4.1B leads to destabiliza-
tion of AGSJs at the paranodes and complete disorganization of
the juxtaparanodal complexes. We also show that 4.1B mutants
generated previously (Yi et al., 2005) have proper localization of
paranodal proteins even after 1 year in the PNS, and that 4.1R is
not involved in paranodal organization or rescue of 4.1B mutant
paranodes. Together, our results establish an important role of 4.1B
as a cytoskeletal adaptor protein that links axoglial junctional com-
plexes with axonal cytoskeleton to ensure long-term stability and
maintenance of axonal domains in myelinated axons.
Materials and Methods
Animals. All animal experiments were performed according to Univer-
sity of North Carolina Institutional Animal Care and Use Committee-
approved guidelines for ethical treatment of laboratory animals. 4.1B/
Epb4.1l3 knock-out mice described previously (Yi et al., 2005) and
transgenic mice expressing Cre recombinase under the ubiquitous
-Actin promoter (-Actin-Cre) were purchased from The Jackson
Laboratory.
Generation of 4.1B/Epb4.1l3 conditional mutants. The 4.1B/Epb4.1l3
locus spans 133 kb of genomic DNA and generates several alternatively
spliced mRNAs (see www.ensembl.org/Mus_musculus). To condition-
ally ablate the 4.1B gene, a targeting construct was generated in which
loxP sites were targeted to flank exon 6. Using BAC recombineering
technology, a BAC clone pBACe3.6 from 129 AB2.2 BAC library contain-
ing the 4.1B locus was targeted such that a neo cassette flanked by FRT,
FRT-loxP sites was inserted in intron 5 and a second loxP site was inserted
in intron 6. Before ES cell targeting, the functionality of the loxP sites, as
well as the expected restriction enzyme digestion patterns in the targeting
vector, were confirmed. The targeting construct was linearized with NotI
followed by electroporation into ES cells. The targeted ES cells were
screened by Southern blotting with a 500 bp probe upstream of the
targeting vector in the 4.1B gene. Two independent targeted clones were
used for generating 4.1B-floxed mice using standard procedures.
Generation of 4.1B antibodies. cDNA sequences encoding a portion of
the U3 domain of 4.1B (amino acids 655–793) were PCR amplified from
a mouse cDNA library, cloned into pET28(a) vector (Novagen), and
expressed in Escherichia coli BL21(DE3). The recombinant protein was
purified over a Ni-Sepharose column and used as an antigen to immu-
nize rabbits and guinea pigs, as described previously (Bhat et al., 2001).
Tissue preparation, antibodies, and immunostaining. The following an-
tisera were previously described: guinea pig and rabbit anti-Caspr (Bhat
et al., 2001; Pillai et al., 2009; Thaxton et al., 2010), guinea pig anti-NF186
and rat anti-pan Neurofascin (Pillai et al., 2009; Thaxton et al., 2010), rat
anti-Ankyrin G (AnkG) and rabbit anti-Caspr2 (Thaxton et al., 2010),
rabbit polyclonal anti-4.1R and 4.1N (Kang et al., 2009), and rabbit and
guinea pig anti-4.1B antibodies (this study). Other primary antibodies
used include the following: mouse anti-Kv1.1 (University of California
Davis/NIH NeuroMab Facility; K20/78), mouse anti-Kv1.2 (University
of California Davis/NIH NeuroMab Facility; K14/16), mouse anti-
PSD95 (University of California Davis/NIH NeuroMab Facility; K28/
43), and rabbit anti--Tubulin (Tub) (Cell Signaling). Secondary
antibodies used for immunofluorescence were Alexa Fluor-488, -568,
and -647 conjugated (Invitrogen). The HRP-conjugated secondary anti-
bodies were purchased from Jackson ImmunoResearch.
Tissues used for immunostaining were prepared as previously de-
scribed (Thaxton et al., 2010). Briefly, sciatic nerves were removed from
anesthetized littermate wild type and mutants of either sex and fixed in
4% paraformaldehyde in PBS for 30 min at 4°C. The nerves were washed
with PBS several times and either stored at 4°C or immediately teased.
The nerves were teased into individual fibers in PBS, mounted on glass
slides, and dried overnight at room temperature, followed by storage at
80°C or immediate processing by treatment with acetone at 20°C for
20 min and several washes with PBS, followed by immunostaining. For
spinal cord sections, wild type and mutants of either sex were deeply
anesthetized and transcardially perfused with saline buffer followed by
ice-cold 4% paraformaldehyde in PBS. The spinal cord was dissected out
and postfixed in 4% paraformaldehyde overnight at 4°C. The tissues were
rinsed several times in PBS and sectioned to 30 m using a Vibratome
(Leica). The spinal cord sections were then immediately immunostained
as previously described (Garcia-Fresco et al., 2006; Pillai et al., 2009).
RNA preparation and RT-PCR. DRGs from -Act-Cre;4.1BFlox,
4.1B /, and control littermate mice of either sex were collected and
simultaneously processed in RNAlater Stabilization Reagent (QIAGEN).
Total RNA was isolated using QIAshredder columns (QIAGEN) and
RNeasy Mini Kit (QIAGEN). RNA concentration was estimated and
equal amounts of RNA were used for reverse transcription followed by
PCR amplification using the MyTaq One-Step RT-PCR kit (Bioline).
Primers used for PCR were as follows: 4.1B, 5-CTGGTT-
GGACCCTGCTAAGG-3 and 5-CTTGGCATGGTGTAAGTCC-3;
4.1R, 5-AAGAGTTTAGCGGCTGAAGC-3 and 5-CGGGCTTCTGGGA-
GGCTT-3; and Actin, 5-GCTCCGGCATGTGCAA-3 and
5-AGGATCTTCATGAGGTAGT-3.
Immunoblotting and immunoprecipitation. Sciatic nerves from litter-
mate wild type and mutants of either sex were excised and crushed using
a glass homogenizer in ice-cold lysis buffer (50 mM Tris-HCl, pH 7.5, 150
mM NaCl, 10 mM EDTA, 1% Triton X-100, 1% SDS, and a protease
mixture tablet). The lysate was incubated on ice for 30 min and centri-
fuged at 16,000  g for 20 min at 4°C. The supernatant was used for
protein estimation and immunoblotting.
Spinal cords from littermate wild type and mutants of either sex were
excised and either directly processed or frozen at 80°C. Spinal cords
were homogenized using a glass mortar and pestle on ice with 1 ml of
ice-cold homogenization buffer (50 mM Tris-HCl, pH 7.5, 50 mM NaCl,
320 mM sucrose, 10 mM EDTA, pH 8.0, and a protease inhibitor mixture
tablet). The homogenate was centrifuged at 1000  g for 10 min at 4°C.
The supernatant was collected and subjected to additional centrifugation
at 100,000  g for 30 min at 4°C. The resulting pellet was then resus-
pended in lysis buffer (50 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM
EDTA, 1% Triton X-100, and a protease inhibitor mixture tablet) and
incubated for 30 min at 4°C with occasional trituration followed by
centrifugation at 100,000  g for 30 min at 4°C and the supernatant was
collected as the final lysate. Protein concentrations of the lysate were
determined using the Lowry assay (BC assay; Bio-Rad).
For immunoprecipitation (IP), immobilized protein A-Sepharose
beads (Thermo Fisher Scientific) were washed with PBS and incubated
with either primary antibodies for 2– 4 h at 4°C (antibody-bound beads)
or 500 g of total protein for 1–2 h at 4°C (preclear beads). The antibody-
bound beads were washed once, and the lysate from the preclear beads
was added and rotated overnight at 4°C. After brief centrifugation, the
supernatant was collected as the post-IP material. The preclear and IP
beads were washed three times with wash buffer (50 mM Tris-HCl, pH
7.5, 50 mM NaCl). Lysate, preclear beads, IP beads, and post-IP material
were resolved by SDS-PAGE and transferred onto nitrocellulose mem-
branes, followed by immunoblotting procedures described above.
Transmission electron microscopy. Transmission electron microscopy
of age-matched wild-type, -Act-Cre;4.1BFlox, and 4.1B / mutant mice
of either sex was performed essentially as described previously (Garcia-
Fresco et al., 2006; Pillai et al., 2009; Thaxton et al., 2010).
Image analysis. Confocal images were captured with a Bio-Rad Radi-
ance 2000 laser-scanning system attached to a Zeiss Axioplan2 micro-
scope. Scanning parameters were optimized for wild-type tissues and
maintained for scanning the mutant tissues. The immunofluorescence
8014 • J. Neurosci., June 1, 2011 • 31(22):8013– 8024 Buttermore et al. • Band 4.1B in Axonal Domain Organization
images shown are Z stacks of four to eight sections with a scan step of 0.25
m. Adobe Photoshop was used for assembling all figures.
Results
Developmental expression of 4.1B and generation of
4.1B-null mutants
Members of the 4.1 protein family are cytoskeletal adaptors that
link membrane proteins to the underlying cytoskeleton (Peters et
al., 1998; Hoover and Bryant, 2000). 4.1B, a member of this fam-
ily, is expressed in the nervous system and is highly enriched at
the paranodal and juxtaparanodal domains in myelinated axons
(Ohara et al., 2000). Based on 4.1B subcellular localization and its
binding with Caspr and Caspr2 (Ohara et al., 2000; Denisenko-
Nehrbass et al., 2003), it was hypothesized that 4.1B links axoglial
junctions or scaffolds with the axonal cytoskeleton. The primary
structure of 4.1B contains a FERM domain, a spectrin/actin bind-
ing domain (SAB), a C-terminal domain (CTD), and three
unique regions U1–U3 (Fig. 1A). We generated antibodies to the
U3 unique region of 4.1B (Fig. 1A, black bar) and performed
immunostaining of teased sciatic nerve fibers (PNS) and spinal
cord sections (CNS) to establish the subcellular localization of
4.1B in the PNS and CNS (Fig. 1B,C). As shown in Figure 1B,
4.1B is enriched at the paranodes and juxtaparanodes (Fig. 1Ba,
red arrows) and overlaps with the paranode-specific protein,
Caspr (Fig. 1Bb). A merged image (Fig. 1Bc) clearly shows that
4.1B is enriched in the juxtaparanodal region (red arrow) and is
not expressed at the nodes (Fig. 1Bc, arrow). Similarly, in the
CNS, 4.1B is enriched at the paranodes and juxtaparanodes but is
not present at the nodes (Fig. 1Ca– c). To determine when 4.1B
expression begins during postnatal development, we performed
immunoblot analysis of 4.1B from postnatal day 2 (P2) to P24
(Fig. 1D). This revealed that two major isoforms of 4.1B (145 and
125 kDa) are expressed in the spinal cord throughout early post-
natal development. We immunoblotted the lysates against Caspr,
which revealed that Caspr is also expressed throughout postnatal
development, as has been reported previously (Bhat et al., 2001).
4.1B mouse mutants have been previously generated using
conventional methods (Yi et al., 2005). As these presumed 4.1B-
null mutants did not reveal any developmental or behavioral
deficits, concerns were raised whether some 4.1B protein iso-
forms might still be expressed from the disrupted 4.1B locus. To
address this issue, we took advantage of the detailed 4.1B genomic
information to generate a floxed allele of 4.1B that would essen-
tially ablate all isoforms of 4.1B on Cre-mediated recombination
(Fig. 1E) (see Materials and Methods). A targeting construct was
generated in which exon 6 (which encodes a portion of the FERM
domain) was flanked with loxP sites (Fig. 1E) and deletion of
exon 6 would cause a frameshift resulting in a premature stop
codon in exon 7 (Fig. 1E, red asterisk). ES cell clones that carried
a properly targeted 4.1B floxed allele were identified by Southern
analysis (Fig. 1F). After germ line transmission, mice were geno-
typed using a combination of primers (Fig. 1E), which revealed
various genotypes (Fig. 1G). Homozygous 4.1BFlox mice were
born with expected Mendelian frequency and did not reveal any
obvious behavioral or development deficits (data not shown).
After Cre-mediated recombination using the ubiquitous
-Actin-Cre (Act-Cre), littermate mice with wild-type (/) or
-Act-Cre;4.1BFlox genotype were analyzed by immunoblotting.
As shown in Figure 1H, spinal cord lysates from -Act-Cre;
4.1BFlox show complete loss of 145 and 125 kDa 4.1B protein
isoforms, which were present in the wild-type lysates, indicating
that 4.1B was ablated in -Act-Cre;4.1BFlox mice. To ensure that
4.1B was also absent in the PNS myelinated axons, we performed
immunostaining against 4.1B, paranodal Caspr, and nodal
Ankyrin G (ANK) in teased sciatic nerves from littermate wild-
type (/) and -Act-Cre;4.1BFlox mice (Fig. 1 I, J). As shown in
Figure 1 J, 4.1B immunoreactivity is completely absent in -Act-
Cre;4.1BFlox fibers (Fig. 1 Ja, red; compare with Ia,d). Interest-
ingly, the paranodal localization of Caspr in -Act-Cre;4.1BFlox
sciatic nerve fibers was altered, displaying punctate and stretched
localization (Fig. 1 Jb,d, green; compare with Ib,d). The nodal
ANK was not affected (Fig. 1 Jc,d, arrows; compare with Ic,d). To
further confirm that this altered Caspr localization reflected a
disorganization of other paranodal proteins, we immunostained
-Act-Cre;4.1BFlox sciatic nerve fibers against Neurofascin
(NFAS) (which recognizes both NF155 and NF186), Caspr, and
ANK. The wild-type fibers revealed a typical paranodal localiza-
tion of NF155 (Fig. 1Ka, NFAS, green arrowheads) and Caspr
(Fig. 1Kb, red arrowheads) at the paranodes and ANK (Fig.
1Kc,d, blue, arrow) at the nodes and all in the merged image (Fig.
1Kd). In -Act-Cre;4.1BFlox sciatic nerve fibers, both Caspr and
NF155 localization at the paranodes was disrupted, and their
distribution stretched away from the paranodes (Fig. 1La,b,d,
asterisks). The ANK localization was normal at the nodes (Fig.
1Lc,d, blue, arrow). Together, these results demonstrate that we
have generated 4.1B-null mutants and that loss of 4.1B in -Act-
Cre;4.1BFlox mice affects the localization of paranodal proteins in
myelinated axons. These results are in contrast to those of Hor-
resh et al. (2010), who reported that paranodal proteins are not
altered in 4.1B mutants (see below).
4.1B is required for the organization and stabilization of the
paranodal and juxtaparanodal regions in myelinated axons
To determine the consequences of loss of 4.1B on axonal domain
organization, we decided to analyze both 4.1B mutants [i.e.,
-Act-Cre;4.1BFlox (this study) and 4.1B/ generated previously
(Yi et al., 2005)]. To date, no detailed phenotypic characteriza-
tion of myelinated axons in any 4.1B mutants has been per-
formed. In this study, we examined the localization of well
characterized paranodal and juxtaparanodal proteins in teased
sciatic nerve fibers and spinal cord sections (Figs. 2, 3). In wild-
type (/) sciatic nerve fibers, 4.1B is enriched at the paranodes
and juxtaparanodes and also localizes along the length of the
internode (Fig. 2Aa, red). Caspr served as a marker for the para-
Table 1. Phenotypic differences between two independently generated 4.1B
mutant alleles
Phenotype -Act-Cre;4.1BFloxa 4.1B /
b
Sciatic nerve
Paranodal proteins Abnormal localizationc Normal localizationd
Paranodal AGSJs Missing transverse septa No missing transverse septa
Destabilized AGSJs Normal AGSJs
Juxtaparanodal proteins Abnormal localization Abnormal localization
Spinal cord
Paranodal proteins Abnormal localizatione Normal localizationf
Paranodal AGSJs Missing transverse septa Missing transverse septa
Destabilized AGSJs Destabilized AGSJs
Juxtaparanodal proteins Abnormal localization Abnormal localization
4.1R localization Not detected at the paranodes Not detected at the paranodes
4.1R mRNA levels in DRGs No change No change
a4.1B mutants generated in this study.
b4.1B mutants generated by Yi et al. (2005).
cParanodal proteins Caspr and NF155 show abnormal localization with stretched morphology and gaps.
dParanodal proteins Caspr and NF155 show normal localization and morphology.
eParanodal protein Caspr shows normal localization at P30, but at P130 the paranodal areas show gaps and abnor-
mal morphology.
fParanodal protein Caspr shows relatively normal localization and morphology.
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nodes (Fig. 2Ab, green), and the cytoskel-
etal adaptor protein AnkyrinG (AnkG)
(Fig. 2Ac, blue) was used as a nodal
marker. A merged image of all the mark-
ers is shown in Figure 2Ad (arrow points
at the node). In 1-month-old -Act-Cre;
4.1BFlox sciatic nerves, 4.1B is absent (Fig.
2Ba), whereas AnkG (Fig. 2Bc) localiza-
tion remains intact at the nodes. The
Caspr localization is elongated and dis-
rupted at the paranodes in -Act-Cre;
4.1BFlox sciatic nerves (Fig. 2Bb,d,
asterisks). At 4 months, in -Act-Cre;
4.1BFlox sciatic nerves, 4.1B is absent, as
expected (Fig. 2Ca), and AnkG (Fig. 2Cc)
remains at the nodes. The Caspr localiza-
tion at the paranodes in 4-month-old
-Act-Cre;4.1BFlox sciatic nerves is broken
and occasionally stretches toward the jux-
taparanodes. Additional examination of
1- and 4-month-old -Act-Cre;4.1BFlox
sciatic nerves revealed that all juxtaparan-
odal markers Kv1.1 (Fig. 2Ea,d;Fa,d),
Kv1.2 (data not shown), PSD95 (data not
shown), and Caspr2 (data not shown)
were diffuse and failed to localize properly
at the juxtaparanodes, compared with
wild-type fibers (Fig. 2Da,d) (data not
shown). In 1-month-old -Act-Cre;
4.1BFlox sciatic nerves, paranodal Caspr
(Fig. 1Lb,d; 2Bb,d;Eb,d, asterisks) and
NF155 (Fig. 1La,d, asterisks) localization
were altered and showed diffuse distribu-
tion at the paranodes, often stretching
into the juxtaparanodal areas. Nodal
markers NF186 (Fig. 2Ec,d) and ANK
(Figs. 1Lc,d; 2Bc,d) were not affected. In
addition, Caspr (Fig. 2Cb,d;Fb,d;Hb,d, as-
terisks) and NF155 (Fig. 2Ha,d, arrow-
head) localization at the paranodes in
4-month-old -Act-Cre;4.1BFlox sciatic
nerves were relatively more compact than
at 1 month, but still contained broken and
disrupted areas (Hd, arrowhead). These
results indicate that loss of 4.1B affects
juxtaparanodal organization and proper
localization of axoglial junctional compo-
nents at the paranodes (Table 1).
Next, we examined localization of
paranodal Caspr, juxtaparanodal KV1.1,
and nodal ANK in the sciatic nerves of 3
Figure 1. Primary structure and subcellular localization of 4.1B and generation of 4.1BFlox mice. A, Schematic of the primary
structure of mouse 4.1B (deduced from GenBank accession number AF152247) (Parra et al., 2000) shows a FERM domain, a SAB
domain, a CTD, and three unique (U1, U2, U3) domains that are specific to each 4.1 protein. The black bar represents a region in the
U3 domain of 4.1B that was used to generate 4.1B antibodies. B, C, Wild-type teased sciatic nerve fibers (B) and spinal cord sections
(C) immunostained with anti-4.1B (red) and Caspr (green) showing enrichment of 4.1B at the paranodes and the juxtaparanodes
(Ba, Ca, red arrowheads) and Caspr at the paranodes (Bb, Cb, green arrowheads). Note that 4.1B extends beyond the paranodal
area (Bc, Cc, red arrowheads). D, Immunoblots of wild-type spinal cord lysates showing developmental expression of 4.1B (top
panel) and Caspr (bottom panel). E, A partial genomic map of the 4.1B (Epb4.1l3) locus showing exons 5–7. A targeting construct
with loxP sites flanking exon 6. Cre-mediated recombination of the loxP sites resulted in the deletion of exon 6, which inserted a
premature stop codon in exon 7 (red asterisk). F, Southern blot analysis confirming the targeted 4.1BFlox allele. G, PCR amplification
using mouse tail genomic DNA from wild-type (/), heterozygous Floxed (/4.1BFlox), homozygous Floxed (4.1BFlox), and
-Act-Cre-expressing (Act-Cre) mice. Primer combinations used are shown in E. H, Immunoblot analysis of wild-type (/) and
-Act-Cre;4.1BFlox (4.1BAct-Flox) spinal cord lysates using anti-4.1B (top panel) and Tub (bottom panel). Note the loss of both
isoforms of 4.1B in 4.1BAct-Flox mutants (right lane). I, Immunofluorescence of teased sciatic nerve fibers from wild-type (/)
mice (Ia–Id) showing typical localization of 4.1B at the paranodes/juxtaparanodes (Ia, Id, red arrows), Caspr at the paranodes
(CASP, green) (Ib, Id, green arrows), and AnkG at the nodes (Ic, Id, blue, arrow). J, Immunofluorescence of teased sciatic nerve
fibers from 4.1BAct-Flox mutants (Ja–Jd) showing loss of 4.1B (red) (Ja) with disrupted localization of Caspr in the paranodal region
(Jb, green asterisks) but normal AnkG localization at the node (Jc, Jd, arrow). K, Immunofluorescence of teased sciatic nerve fibers
from wild-type (/) mice (Ka–Kd) showing typical localization of NFAS (which recognizes both NF155 and NF186) at the
4
paranodes (green arrowheads) and nodes (Ia, Id, green),
Caspr at the paranodes (Kb, Kd, red), and AnkG at the nodes
(Kc, Kd, blue, arrow). In Kd, the arrowhead points to merge of
NFAS and CASP at the paranodes and the arrow points to the
node. L, Immunofluorescence of teased sciatic nerve fibers
from 4.1BAct-Flox mutants (Ja–Jd) showing disrupted NFAS
(Ja, green, asterisks) and Caspr localization at the paranodal
region (Jb, red, asterisks). AnkG localization at the node is not
affected (Lc, Ld). Note that localization of both paranodal pro-
teins NFAS and CASP is disorganized. Scale bars: I–L, 10 m.
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month 4.1B/ mice (Yi et al., 2005). As expected, 4.1B is absent
at the paranodes and juxtaparanodes in 4.1B/ mutant fibers
(Fig. 2 Ja, red). Interestingly, as observed by Horresh et al. (2010),
Caspr (Fig. 2 Jb,d;Lb,d, green) localization at the paranodes was
not affected in 4.1B/ mutant fibers. KV1.1 localization at the
juxtaparanodes is compromised in 4.1B/ mutants (Fig. 2La,d,
red, asterisks), as is also seen in -Act-Cre;4.1BFlox mutants (Fig.
2Ea,d;Fa,d, red). In addition, Kv1.2, Caspr2, and PSD95 were
similarly mislocalized from the juxtaparanodes (data not shown).
These data indicate that, in 4.1B/ mutants, localization of the
juxtaparanodal proteins is compromised, whereas the paranodal
components are not affected (Table 1).
We also analyzed the localization of paranodal and juxtapara-
nodal proteins in the spinal cords of -Act-Cre;4.1BFlox and
4.1B/ mutants. In wild-type (/) spinal cord sections, 4.1B
is enriched at the paranodes and the juxtaparanodes (Fig. 3Aa,
red). In addition, Caspr (Fig. 3Ab,Db,
green), AnkG (Fig. 3Ac, blue), and NF186
(Fig. 3Dc, blue) are localized at the paran-
odes and nodes, respectively (Fig.
3Ad,Dd). As in the PNS, 4.1B is absent in
1- and 4-month-old -Act-Cre;4.1BFlox
spinal cord myelinated axons (Fig.
3Ba,Ca, red). However, the paranodal lo-
calization of Caspr (Fig. 3Bb,d;Eb,d,
green) was not disrupted in 1-month-old
-Act-Cre;4.1BFlox spinal cord axons. In-
terestingly, in 4-month-old -Act-Cre;
4.1BFlox spinal cord myelinated axons,
Caspr (Fig. 3Cb,d;Fb,d, green) localiza-
tion was not normal. There were gaps be-
tween paranodal Caspr and the nodal
proteins AnkG and NF186 (Fig. 3Cc,d;
Fc,d, arrowheads). Again, the juxtaparan-
odal Kv1.2 was mislocalized in both 1- and
4-month-old -Act-Cre;4.1BFlox mutant
spinal cord axons (Fig. 3Ea,d;Fa,d, red, as-
terisks). AnkG and NF186 were both
maintained at the nodes in all -Act-Cre;
4.1BFlox mutants (Fig. 3Bc,d;Cc,d;Ec,d;
Fc,d, respectively). Analysis of 4.1B/
mutant spinal cord axons also revealed
absence of 4.1B in 4.1B/ mutants (Fig.
3Ha, red). Paranodal Caspr localization
remained relatively unaffected (Fig. 3Hb-
,d;Jb,d, green). The juxtaparanodal Kv1.1
was mislocalized (Fig. 3Ja,d, red, arrow-
heads). Nodal AnkG (Fig. 3Hc,d, blue)
and NF186 (Fig. 3Jc,d, blue) were not
affected. The juxtaparanodal proteins
Kv1.2, PSD95, and Caspr2 were similarly
mislocalized in the spinal cords of both
4.1B mutants (data not shown). Together,
the immunohistochemical results indi-
cate that 4.1B is critical for proper organi-
zation of the juxtaparanodal region in
both the PNS and the CNS, and that 4.1B
is required for the stabilization of the
paranodes in the PNS, and progressively
in the CNS (Table 1).
Molecular interactions between
paranodal Caspr and complex
formation between juxtaparanodal Caspr2, Kv1.2, and 4.1B
To further investigate the striking phenotypic differences be-
tween the PNS and CNS myelinated fibers, we immunoblotted
sciatic nerve and spinal cord lysates from wild type (/),
4.1B/, and -Act-Cre;4.1BFlox mutants (Fig. 4A,B). Surpris-
ingly, we discovered that the wild-type sciatic nerves express close
to eight isoforms of 4.1B, some with molecular weights exceeding
180 kDa, in contrast to the CNS, where only two major isoforms
(145 and 125 kDa) are expressed (Fig. 4, compare Aa, Ba). All of
these 4.1B isoforms were absent in both 4.1B mutants (Fig.
4Aa,Ba). Immunoblotting against Caspr did not reveal any sig-
nificant changes in the relative Caspr levels between wild-type
and 4.1B mutants (Fig. 4Ab,Bb). In addition, immunoblotting
against juxtaparanodal proteins Kv1.2 and Caspr2 did not reveal
any significant differences in their levels between the wild-type
and 4.1B mutant sciatic nerves (Fig. 4Ac,d). For protein loading
Figure 2. Loss of 4.1B disrupts paranodal and juxtaparanodal organization in the PNS myelinated axons. A–H, P30 wild-type
(/) (Aa–Ad, Da–Dd, Ga–Gd), P30 -Act-Cre;4.1BFlox (Ba–Bd, Ea–Ed), and 4-month-old -Act-Cre;4.1BFlox (Ca–Cd, Fa–
Fd, Ha–Hd) sciatic nerve fibers immunostained against 4.1B (Aa, Ba, Ca, red), Kv1.1 (Da, Ea, Fa, red), Caspr (Ab–Hb, green),
pan-NFAS (Ga, Ha), AnkG (Ac–Cc, blue), NF186 (Dc–Hc, blue), and merged images (Ad–Hd). Note that 4.1B is absent from the
mutant fibers (Ba, Ca) and Kv1.1 (Ea, Ed; Fa, Fd) is either undetectable at the juxtaparanodes or severely mislocalized. In all 4.1B
mutant panels, Caspr (Bb, Bd; Cb, Cd; Eb, Ed; Fb, Fd; Hb, Hd, asterisks) and paranodal NF155 (NFAS) (Ha, Hd, arrowhead) fail to
localize properly at the paranodes. Nodal AnkG or NF186 are not affected (Ac,d–Hc,d, arrows). I–L, P90 wild-type (/) (Ia–Id,
Ka–Kd) and 4.1B / (Yi et al., 2005) (Ja–Jd, La–Ld) sciatic nerve fibers immunostained against 4.1B (Ia, Ja, red), Kv1.1 (Ka, La,
red), Caspr (Ib–Lb, green), AnkG (Ic, Jc, blue), NF186 (Kc, Lc, blue), and merged images (Id–Ld). 4.1B is absent from the mutant
fibers, as expected (Ja, Jd), and Kv1.1 is either undetectable at the juxtaparanodes or severely mislocalized (La, Ld, asterisks).
However, Caspr localizes properly at the paranodes (Jb, Jd; Lb, Ld, asterisks). Nodal AnkG or NF186 are not affected (Jc, Jd; Kc, Kd;
Lc, Ld, arrows). Scale bars, 10 m (all).
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control, membranes were immunoblotted against Tub (Fig.
4Ae,Bc). We also wanted to determine whether disruption of the
paranodal axoglial junctions in Caspr (Bhat et al., 2001) and Cgt
(Dupree et al., 1999) mutants affected 4.1B protein levels in the
spinal cords. As shown in Figure 4Ca, 4.1B protein levels are
relatively unchanged between wild-type and the paranodal mu-
tants. Similarly, Caspr levels are not affected in 4.1B and Cgt
mutant spinal cords (Fig. 4Cb). For protein loading control,
membranes were immunoblotted against -Tubulin (Fig. 4Cc).
These data show that sciatic nerves express multiple forms of 4.1B
and that loss of 4.1B or Caspr only affects the subcellular local-
ization of Caspr and 4.1B, respectively, and that stable expression
of each of these proteins is not dependent on the other paranodal
proteins.
Our immunohistochemical data showed that 4.1B is required
for the localization of potassium channels Kv1.1 and Caspr2 to
the juxtaparanodal region (Figs. 2, 3). Previous studies revealed
that a possible mechanism for potassium channel retention at the
juxtaparanodal region could be attributable to molecular inter-
actions between Caspr2 and potassium channels (Poliak et al.,
2003; Horresh et al., 2010). We therefore examined whether 4.1B
is required for Caspr2 interactions with potassium channels. It is
established that 4.1B interacts with Caspr
(Denisenko-Nehrbass et al., 2003; Garcia-
Fresco et al., 2006; Ogawa et al., 2006) and
Caspr2 (Denisenko-Nehrbass et al., 2003;
Horresh et al., 2010). As shown in Figure
4D, a and b, immunoprecipitation with
anti-Caspr antibodies using spinal cord
lysates coprecipitated 4.1B. Additionally,
in the wild-type spinal cord lysates, IPs
with anti-Caspr2 antibodies coprecipi-
tated potassium channels Kv1.2 (Fig.
4Ea,a). Caspr2 and Kv1.2 still formed a
molecular complex in the absence of 4.1B
in -Act-Cre;4.1BFlox (Fig. 4Eb,b) and
4.1B/ (Fig. 4Ec,c) spinal cord lysates.
These results suggest that 4.1B is critical
for the maintenance of the juxtaparanodal
complex of Caspr2 and potassium chan-
nels and not the formation of this mo-
lecular complex. Together, our results
demonstrate that 4.1B is a critical compo-
nent of the paranodal and juxtaparanodal
domains and that expression of multiple
isoforms in the PNS versus the CNS may
allow for differential function of 4.1B in
axonal domain organization.
4.1B is critical for the stability of the
paranodal axoglial septate junctions
Our immunofluorescence studies re-
vealed striking juxtaparanodal disorgani-
zation in both the PNS and the CNS in
-Act-Cre;4.1BFlox and 4.1B/ mutants
(Figs. 2, 3). In addition, we found severe
paranodal destabilization in the PNS, and
progressive paranodal disruption in the
CNS, of -Act-Cre;4.1BFlox mice (Fig. 3).
To further investigate the role of 4.1B in
axonal domain organization, we used
electron microscopy to specifically look at
the ultrastructural architecture of the
paranodal region in wild-type, -Act-Cre;4.1BFlox, and 4.1B/
mutant sciatic nerve and spinal cord myelinated axons (Figs. 5,
6). A low-magnification electron micrograph of P30 littermate
wild-type (/) (Fig. 5A) and -Act-Cre;4.1BFlox mutant (Fig.
5B) sciatic nerve myelinated axons, at the level of the nodal/
paranodal region, shows a typical domain distinction between
the nodal and the paranodal region. At this magnification, the
wild-type and -Act-Cre;4.1BFlox mutant fibers look essentially
similar with respect to the presence of individual domains. At a
higher magnification, the paranodal AGSJs show characteristic
electron-dense septa between the myelin loops and the axo-
lemma in wild-type fibers (Fig. 5C, arrowheads). In 1-month-old
-Act-Cre;4.1BFlox mutant fibers, a few electron-dense septa can
be found (Fig. 5D, arrowhead), whereas most septa appear diffuse
and ill defined (Fig. 5D, asterisks), suggesting that septa may be
undergoing destabilization. In 3-month-old -Act-Cre;4.1BFlox
mutant fibers, the electron density of the septa is diffuse and fuzzy
(Fig. 5E,F, asterisks). In comparison, ultrastructural analysis of
previously generated 4.1B/ mutants revealed no clear differ-
ences in the ultrastructural morphology of the paranodal axoglial
septa at 3 months (Fig. 5H; compare with G, arrowheads). How-
ever, at 6 month and 1 year time points, septa were missing in the
Figure 3. Mislocalization of juxtaparanodal components and destabilization of the paranodes in the CNS myelinated axons of
4.1B mutants. A–F, P30 wild-type (/) (Aa–Ad, Da–Dd), P30 -Act-Cre;4.1BFlox (Ba–Bd, Ea–Ed), and 4-month-old -Act-
Cre;4.1BFlox (Ca–Cd, Fa–Fd) spinal cord sections immunostained against 4.1B (Aa, Ba, Ca, red), Kv1.2 (Da, Ea, Fa, red), Caspr
(Ab–Fb, green), AnkG (Ac, Bc, Cc, blue), NF186 (Dc, Ec, Fc, blue), and merged images (Ad–Fd). Note that 4.1B is absent from the
mutant fibers (Ba, Ca), and Kv1.1 (Ea, Ed; Fa, Fd) is either undetectable at the juxtaparanodes or severely mislocalized (Ed, Fd,
asterisks). In P30 4.1BFlox mutants, Caspr localization in the CNS paranodes is not severely affected. In 4-month-old 4.1BFlox
mutants, gaps form between the node and Caspr localization (Cd, Fd, arrowheads). G–J, P90 wild-type (/) (Ga–Gd, Ia–Id)
and 4.1B / (Ha–Hd, Ja–Jd) spinal cord sections immunostained against 4.1B (Ga, Ha, red), Kv1.1 (Ia, Ja, red), Caspr (Gb–Jb,
green), AnkG (Gc, Hc, blue), NF186 (Ic, Jc, blue), and merged images (Gd–Jd). Note that 4.1B is absent as expected (Ha) and Kv1.1
(Ja, Jd) is either undetectable at the juxtaparanodes or severely mislocalized (Jd, arrowheads). Caspr localization in the CNS
paranodes in 4.1B / is not severely affected. Scale bars, 5 m (all).
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sciatic nerve paranodal regions (data not shown) in 4.1B/ mu-
tants. Quantification of the percentage of paranodes with a nor-
mal array of septa in the sciatic nerve of each genotype at 3
months revealed that, in the wild-type mice, 90% of paranodes
contain a full complement of septa. In sciatic nerve fibers of
3-month-old -Act-Cre;4.1BFlox mice, only 60% of the paranodes
counted retained a full complement of septa, whereas 75% of
paranodes in 3-month-old 4.1B/ sciatic nerves contained a
normal set of septa. In -Act-Cre;4.1BFlox mice, paranodes often
displayed severe morphological defects, which occluded visual-
ization of missing septa suggesting that paranodal disorganiza-
tion was more severe than were included in the quantification.
Together, these results are consistent with our immunostaining
results (Fig. 2), which showed disrupted localization of the para-
nodal proteins in -Act-Cre;4.1BFlox mutant sciatic nerve fibers.
Next, we analyzed the spinal cord myelinated axons in 1- and
3-month-old wild type and -Act-Cre;4.1BFlox mutants. As
shown in Figure 6A, wild-type spinal cord myelinated axons dis-
play a uniform arrangement of septa between the myelin loops
and the axolemma (Fig. 6A, arrowheads). The fibers from
1-month-old -Act-Cre;4.1BFlox mutant spinal cords revealed the
presence of axoglial septa in some regions (Fig. 6B, arrowhead)
and complete loss of septa in other regions at the same paranodes
(Fig. 6B–D, asterisks). In the areas in which septa are missing, the
axolemma showed clear detachments from the myelin loops and
loss of electron densities (Fig. 6B–D, white arrows). At 3 months,
some electron densities are still found in -Act-Cre;4.1BFlox mu-
tant spinal cords (Fig. 6F, arrowhead). However, many paran-
odal loops were detached from the axonal membrane (Fig. 6F,G,
arrows). In addition, larger areas were found with missing septa
(Fig. 6H, white arrow), and detached axolemma (Fig. 6G,H, as-
terisks). Detachment of paranodal loops abutting the node agrees
with immunohistochemical data revealing gaps between the
nodal proteins and Caspr in 4-month-old -Act-Cre;4.1BFlox mu-
tant spinal cords (Fig. 3Cd,Fd, arrowheads). The -Act-Cre;
4.1BFlox mutant fibers also revealed accumulation of smooth
endoplasmic reticulum (SER) at the nodal/paranodal regions
(Fig. 6E), suggesting a disruption of the local axonal cytoskele-
ton, as has been previously observed in Caspr, Cgt (Einheber et
al., 2006; Garcia-Fresco et al., 2006), and NfascNF155 (Pillai et al.,
2009) mutants. These data suggest that 4.1B is not required for
the initial organization of the paranodal axoglial septa, but for
their stabilization.
To determine the paranodal defects in the spinal cord myelin-
ated axons in 4.1B/ mutants, we analyzed them at P90, 6
month, and 1 year time points. As shown in Figure 6 I, P90 wild-
type spinal cord myelinated axons showed proper densities and
arrangement of the septa (arrowheads). In contrast, P90 4.1B/
mutants showed myelinated axons with normal septa (Fig. 6 J,
arrowheads) and regions with abnormal or missing septa (Fig. 6 J,
asterisks, white arrow). By 6 months, 4.1B/ mutant myelinated
axons revealed a more prominent loss of septa with increased
spacing between the paranodal lateral loops and the axolemma,
indicating a progressive deterioration of the paranode with age
(Fig. 6K, asterisks). In these fibers, destabilization of septa be-
comes obvious as the densities of these fibers looked diffuse (Fig.
Figure 4. Multiple 4.1B isoforms in sciatic nerves and molecular interactions between 4.1B, Caspr, and Caspr2. A, Immunoblot analysis of wild-type (/), 4.1B /, and -Act-Cre;4.1BFlox
(4.1BAct-Flox) sciatic nerve lysates against 4.1B (Aa), Caspr (Ab), Caspr2 (Ac), Kv1.2 (Ad), and Tub (Ae) reveal expression of approximately eight isoforms of 4.1B in the sciatic nerves, which are absent
in both 4.1B mutants. Caspr levels are unchanged in 4.1B mutants. B, Immunoblot analysis of wild-type (/), 4.1B /, and -Act-Cre;4.1BFlox (4.1BAct-Flox) spinal cord lysates against 4.1B (Ba),
Caspr (Bb), and Tub (Bc) reveal expression of two major isoforms in the CNS, which are absent in both 4.1B mutants. Note that Caspr levels are not affected in 4.1B mutants. C, Immunoblot analysis
of wild-type (/), 4.1B /, Caspr /, and Cgt / spinal cord lysates against 4.1B (Ca), Caspr (Cb), and Tub (Cc) showed that the levels of 4.1B and Caspr are not affected in Caspr and 4.1B
mutants, respectively. Cgt mutants also did not show any changes in 4.1B expression. D, IP analysis using anti-Caspr antibodies (Da) with wild-type (/) spinal cord lysates co-IPs 4.1B (Db). E,
IP analysis using anti-Caspr2 antibodies with wild-type (/) (Ea, Ea), -Act-Cre;4.1BFlox (4.1BAct-Flox) (Eb, Eb), and 4.1B / (Ec, Ec) spinal cord lysates co-IPs Kv1.2 in all the genotypes,
suggesting that Caspr2 interactions with Kv1.2 are independent of 4.1B.
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6K, arrowheads). Analysis of 1-year-old 4.1B/ mutants spinal
cord myelinated axons revealed additional destabilization of the
paranodal regions, with essentially all septa lost and the axo-
lemma detaching from the myelin loops (Fig. 6L,M, asterisks).
The 1-year-old 4.1B/ mutant spinal cord myelinated axons
also revealed accumulation of organelles, including mitochon-
dria and SER at the nodal/paranodal regions, suggesting a disrup-
tion of the axonal cytoskeleton, as observed in the sciatic nerves
(Fig. 6N, arrowheads) (data not shown). To directly compare the
phenotypes in the two 4.1B-null mice, the number of paranodes
with a complete set of septa at 3 months were quantified. In
wild-type spinal cords, 94% of paranodes contain a full set of
septa. In -Act-Cre;4.1BFlox spinal cords, only 36% of the paran-
odes retain a complete set of septa, whereas 50% of the paranodes
in 4.1B/ spinal cords maintain a complete set of septa. Inter-
estingly, in the spinal cord of -Act-Cre;4.1BFlox mice, loss of
septa resulted in destabilization of paranodal loops, especially in
the region abutting the node (Fig. 6F). Quantification revealed
that 72% of paranodes in wild-type spinal cords contain a com-
plete set of loops contacting the paranodal axolemma. In the
-Act-Cre;4.1BFlox spinal cords, only 33% of paranodes main-
tained loops in contact with the axolemma. In comparison, in
4.1B/ spinal cords, 71% of paranodes retained a complete set
of loops contacting the axolemma. These data suggest that loss of
4.1B in -Act-Cre;4.1BFlox spinal cords results in destabilization
of the septa and lifting of the paranodal loops from the axo-
lemma. Together, the ultrastructural analyses in -Act-Cre;
4.1BFlox and 4.1B/ mutants demonstrate that 4.1B is critical for
the stabilization of paranodal AGSJs, and that the long-term sta-
bility of the AGSJs is dependent on 4.1B, as it provides a scaffold-
ing link with the paranodal axonal cytoskeleton (Table 1).
4.1R is not expressed at the PNS paranodes or enriched in
4.1B / mutants
One of the underlying reasons suggested to explain a lack of
phenotype at the PNS paranodes in 4.1B/ mutants was that
4.1R was expressed at the mutant paranodes and not at the wild-
type paranodes (Horresh et al., 2010). We wanted to determine
whether -Act-Cre;4.1BFlox mutant sciatic nerves also had in-
creased 4.1R expression at the paranodes, and as controls we used
4.1B/ mutants. Immunostaining of wild-type (/), -Act-
Cre;4.1BFlox, and 4.1B/ sciatic nerve fibers against 4.1R did not
reveal expression of 4.1R at paranodes in any of the genotypes
analyzed (Fig. 7Aa,c–Fa,c, red, arrowheads). Caspr localization
was normal in the wild-type and 4.1B/ mutant fibers and dis-
rupted in -Act-Cre;4.1BFlox mutant fibers (data not shown).
These data show that 4.1R is not expressed at the paranodes and
thus cannot possibly compensate for loss of 4.1B at the paran-
odes. To test the specificity of our 4.1R antibody, we performed
immunoblot analysis of sciatic nerves from wild-type and
4.1R/ mice and confirmed that 4.1R was missing in 4.1R/
sciatic nerves (Fig. 7G) (Shi et al., 1999). We also performed
immunoblot analysis of sciatic nerves and spinal cords from lit-
termate wild type and -Act-Cre;4.1BFlox and 4.1B/ mutants.
As shown in Figure 7, H and I, no significant differences, and
especially no increases, were observed in 4.1R levels between wild
type and both 4.1B mutants. Immunoblotting against Tub was
used as a loading control. To confirm these results, we also com-
pleted RT-PCR with RNA extracted from dorsal root ganglia of
littermate wild type and -Act-Cre;4.1BFlox and 4.1B/ mutants
(Fig. 7J). Primers targeted to amplify DNA from exons 5 through
8 were used to show deletion of exon 6 in the -Act-Cre;4.1BFlox
mice (Fig. 7J). The genotype of 4.1B/ mutants were confirmed
using primers designed to exons 2 through 3, resulting in loss of
the band in this mutant only (data not shown). Importantly, 4.1R
levels were uniform in all genotypes (Fig. 7J). Actin was used as a
housekeeping gene control. Together, the immunostaining, im-
munoblot, and RT-PCR analyses in two independent 4.1B mu-
tants show that 4.1R is not expressed at the paranodes in the
wild-type fibers and that 4.1R does not get enriched at 4.1B mu-
tant paranodes (Table 1).
Discussion
The organization of specialized membrane environments that
create cellular diversification depends on linkage of cellular
membranes with the underlying cytoskeleton (Jekely, 2007). The
4.1 protein family functions to link the plasma membrane with
the actin cytoskeleton (Cohen and Foley, 1982; Conboy, 1993;
Hoover and Bryant, 2000; Sun et al., 2002; Chen et al., 2005). In
the nervous system, the cell adhesion molecules Caspr and
Caspr2 contain 4.1-binding sites, which are required for their
localization to the paranodes and juxtaparanodes, respectively
(Poliak et al., 2003; Traka et al., 2003; Horresh et al., 2010). When
Caspr expression is genetically ablated, AGSJs fail to form, lead-
ing to loss of axonal domain segregation and disrupted paranodal
axonal cytoskeleton (Bhat et al., 2001; Garcia-Fresco et al., 2006),
suggesting that paranodal AGSJs are linked to axonal cytoskele-
ton. In this study, phenotypic analyses of 4.1B mutants showed
that 4.1B is required for the stability of paranodal AGSJs in my-
elinated axons.
Isoform-specific functions of 4.1B in PNS and CNS
myelinated axons
Phenotypic analysis of -Act-Cre;4.1BFlox mutant sciatic nerves
showed paranodal defects as early as P30. The CNS paranodal
Figure 5. 4.1B is required for the stability of paranodal axoglial septate junctions in sciatic
nerve myelinated axons. A–D, Electron micrographs of longitudinal sections through the nodal/
paranodal regions of sciatic nerves from P30 wild type (A, C) (/) and -Act-Cre;4.1BFlox (B,
D). At low magnification, the paranodal myelin loops in the -Act-Cre;4.1BFlox mutant fibers are
properly arrayed and show normal profiles, as in the wild type. At a higher magnification, the
wild-type (/) paranodal loops are tightly apposed and indent the axon, with the charac-
teristic transverse septa (C, black arrowheads). In -Act-Cre;4.1BFlox mutant fibers, the paran-
odal septa display a fuzzy, ill defined appearance (D, asterisks). E, F, Electron micrographs of
paranodal regions of P90 -Act-Cre;4.1BFlox sciatic nerves. Septa are less electron-dense than
wild-type septa, a sign of destabilization (asterisks). G, H, Electron micrographs of longitudinal
sections through the paranodal regions of sciatic nerves from P90 wild type (J, /) and
4.1B / generated by Yi et al. (2005) (K). The paranodal septa in 4.1B / mutants display
similar morphology and density as is seen in the wild-type (/) axons. Scale bars: A, B, 1
m; C–H, 0.2 m.
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defects at P30 were relatively mild, but at P90 transverse septa
were often lost and paranodal loops were coming off the axo-
lemma, indicating an important role for 4.1B in AGSJ stabiliza-
tion. Phenotypic analysis of the previously reported 4.1B mutants
(Yi et al., 2005) did not show disorganized
Caspr localization or loss of paranodal
septa in the PNS at P90, but revealed pro-
gressive destabilization of CNS paranodal
septa at later stages of development. These
variable phenotypes between 4.1B mu-
tants could be attributed to the nature of
4.1B mutations, their genetic back-
grounds, or the multiple splice isoforms
of 4.1B. Strain genetic backgrounds could
be a contributing factor to phenotypic dis-
crepancies between the two 4.1B mutants.
The 4.1B/ mice are on a C57BL/6 back-
ground, whereas the -Act-Cre;4.1BFlox
mice are on a mixed background of
C57BL/6 and 129SvEv. -Act-Cre;4.1BFlox
mice show a consistent phenotype
throughout all mixed lines. We also exam-
ined the localization of 4.1B, Caspr,
AnkG, Kv1.2, and NF186 in each back-
ground strain and did not observe any dis-
ruptions in the localization of these
proteins or the morphology of the paran-
odes (data not shown). These results suggest
that the paranodal phenotypes observed in
-Act-Cre;4.1BFlox mice are attributable to
loss of 4.1B and not attributable to genetic
background of the strains used.
In agreement with previous studies
that showed two 4.1B isoforms in brain
lysates (145 and 125 kDa) (Denisenko-
Nehrbass et al., 2003), we also observed
the same isoforms in the spinal cord. Dif-
ferential alternative splicing in the PNS
versus CNS may allow 4.1B to function in
a tissue-specific manner. The expression
of close to eight different isoforms in the
PNS may explain the variation in pheno-
type seen between PNS and CNS, as well
as the differences between -Act-Cre;
4.1BFlox and 4.1B/ mutants. The phe-
notypic differences may lie in the nature
of the 4.1B mutations, as specific isoforms
may play different roles in domain orga-
nization and stability in the CNS and the
PNS. In 4.1B/ mutants, exon 3 was dis-
rupted by insertion of a puromycin resis-
tance cassette (Yi et al., 2005). It is possible
that some compensatory isoforms or
splice variants remain in 4.1B/ mu-
tants, which may not be detected by our
antibodies directed to the U3 region of
4.1B, or by antibodies directed to the U2
region of 4.1B (Kang et al., 2009) (data not
shown). We believe that our targeted de-
letion of a common exon 6, which en-
codes the middle portion of the FERM
domain, generates a 4.1B-null mutation.
Additional evidence for a 4.1B-null muta-
tion lies in the paranodal disorganization phenotype displayed by
-Act-Cre;4.1BFlox compared with that observed in 4.1B/ mu-
tants, even at 1 year of age. In addition, our immunohistochem-
ical, immunoblot, and RT-PCR analyses did not reveal
Figure 6. 4.1B is required for the stability of paranodal axoglial septate junctions in the spinal cord myelinated axons. A–D, Electron
micrographs of the paranodal regions of P30 spinal cord myelinated fibers from the wild type (/) show paranodal loops tightly
apposed to and indent the axon, with the characteristic septa (A, black arrowheads). In -Act-Cre;4.1BFlox mutant spinal cords, the paran-
odal region displays regions with normal septa (B, arrowheads) and regions in which septa are essentially absent (B–D, asterisks). The
white arrows point to detached axolemma from the paranodal loops (B–D) or breaks in the axolemma (D). E, -Act-Cre;4.1BFlox mutant
myelinated axons often display accumulation of SER and mitochondria at the nodal/paranodal region, as has been previously observed in
Caspr / mutants. F–H, Electron micrographs of the paranodal regions of spinal cord myelinated fibers from P90 -Act-Cre;4.1BFlox
mutants show lifting off of paranodal loops (F, G, arrows), stretches of missing septa (G, H), and detachment of the axolemma (G, H,
asterisks), whereas some septa also remain at this time point (F, arrowhead). I–M, Electron micrographs of the paranodal regions of spinal
cord myelinated fibers from P90 wild type (I) (/), P90 4.1B / mutants (J), P180 4.1B / mutants (K), and P365 4.1B /
mutants (L, M). The spinal cords of P90 4.1B / mutants show paranodal regions with normal septa (arrowheads) and regions with
abnormal or missing septa (J, K, asterisks). In P365 4.1B / spinal cords, majority of the paranodes did not display septa with normal
morphology, but displayed diffuse electron densities (L, arrowheads). Large regions of the paranodes had essentially lost all the septa (M,
asterisks) and displayed thinner axolemma. N, 4.1B / myelinated axons from 1-year-old mutants also displayed accumulation of SER
andmitochondriaatthenodal/paranodalregions(arrowheads),asobservedinP30-Act-Cre;4.1BFlox mutants(seeE).Scalebars:A–D,0.2
m; E, N, 0.5 m; F–H, 0.1 m; I–M, 0.2 m.
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compensatory expression of 4.1R at the paranodes, or an increase
in 4.1R in the sciatic nerves of 4.1B mutants, as was reported by
Horresh et al. (2010). Together, our data demonstrate that 4.1B is
critically required for the stabilization of the paranodal AGSJs
and the juxtaparanodal axoglial scaffolds in myelinated axons.
Organization of axonal domains and localization of 4.1B
A key question that remains unresolved is whether 4.1B is re-
quired in the formation of paranodal and juxtaparanodal do-
mains, or for their stability. In the absence of 4.1B, paranodal
AGSJs are formed (Figs. 5, 6), suggesting that 4.1B is not required
for the formation, but for the stability of AGSJs (Bhat et al., 2001;
Denisenko-Nehrbass et al., 2003; Poliak et al., 2003; Horresh et
al., 2010). Furthermore, disruption of paranodal AGSJs in Caspr
(data not shown) and Contactin (Gollan et al., 2002) mutants
results in diffuse localization of 4.1B along the axon, suggesting
that 4.1B requires AGSJs to become enriched at these domains.
Paranodal localization of 4.1B may also be aided through its in-
teractions with II and II spectrin, which are enriched at the
paranodal region (Garcia-Fresco et al., 2006; Ogawa et al., 2006).
These observations indicate that paranodal and juxtaparanodal
proteins initially cluster independently of 4.1B, and once clus-
tered through axon– glial interaction mechanisms, 4.1B interac-
tions ensure that these axoglial adhesion complexes are
stabilized.
Role of axonal cytoskeleton in stabilizing axon– glial
interactions and septate junctions
The molecular identities of the complexes responsible for stabi-
lizing axonal domains over the life of the axon are not well un-
derstood. At the paranodes, AGSJs are organized by interactions
between Caspr, Cont, and Nfasc NF155 (Bhat et al., 2001; Boyle et
al., 2001; Pillai et al., 2009). Loss of Caspr leads to disorganization
of the paranodal region and axonal cytoskeleton, suggesting that
AGSJs are linked to the axonal cytoskeleton (Garcia-Fresco et al.,
2006; Ogawa et al., 2006). Paranodal disorganization in -Act-
Cre;4.1BFlox mutants provides additional evidence that AGSJs are
linked to axonal cytoskeleton and that 4.1B is required to ensure
stability of the paranodal region. Support for the role of 4.1B as a
cytoskeletal adaptor protein comes from transgenic and rescue
studies that show Caspr lacking its 4.1-binding domain is able to
cluster at paranodes but fails to establish a barrier to prevent
Figure 7. 4.1R is not enriched at sciatic nerve paranodes in 4.1B mutants. A–F, P30 wild-type (/) (Aa–Ac, Ca–Cc, Ea–Ec), -Act-Cre;4.1BFlox (Act-Cre;4.1BFlox) (Ba–Bc, Da–Dc), and
4.1B / (Fa–Fc) sciatic nerves immunostained against 4.1R (Aa,c–Fa,c, red, arrowheads) and NF186 (Ab–Fb, green) and in merged images (Ac–Fc). Note that 4.1R is not expressed or enriched
at mutant paranodes in any of the genotypes. G, Immunoblot analysis of wild-type (/) and 4.1R / sciatic nerve lysates against 4.1R (Ga) and Tub (Gb) reveal the specificity of the 4.1R
antibody with the 80 kDa 4.1R present in wild-type lysate, but not 4.1R / lysate (Ga). H, Immunoblot analysis of wild-type (/), -Act-Cre;4.1BFlox (4.1BAct-Flox), and 4.1B / sciatic nerve
lysates against 4.1R (Da) and Tub (Db) reveal no change in 4.1R levels in either of the 4.1B mutants, compared with wild type. I, Immunoblot analysis of wild-type (/), -Act-Cre;4.1BFlox
(4.1BAct-Flox), and 4.1B / spinal cord lysates against 4.1R (Ia) and Tub (Ib) reveal no change in 4.1R expression in both 4.1B mutants (asterisks), compared with wild type. J, RT-PCR analyses of
wild-type (/), -Act-Cre;4.1BFlox (Act-Cre;4.1BFlox), and 4.1B / dorsal root ganglia using primers specific to 4.1B, 4.1R, and Actin (Act) reveal no change in the levels of 4.1R mRNA in either
of the 4.1B mutants, compared with wild type. Scale bars, 10 m.
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juxtaparanodal components from entering paranodal space
(Horresh et al., 2010). Furthermore, Caspr with a deleted
C-terminus can reach, but fails to stabilize at paranodes, suggest-
ing that the C-terminus is essential for Caspr stabilization
(Gollan et al., 2002). Protein 4.1B likely stabilizes the paranodes
through direct interactions with Caspr and other cytoskeletal
proteins such as AnkB and II- and II-spectrin (Garcia-Fresco
et al., 2006; Ogawa et al., 2006). Interestingly, domain disorgani-
zation in 4.1B mutants did not result in conduction velocity dif-
ferences in P30 wild-type, -Act-Cre;4.1BFlox, or 4.1B/ sciatic
nerve fibers (data not shown). In addition, neither 4.1B mutants
display obvious behavioral deficits, as of 4 months of age. How-
ever, precise electrophysiological recordings of individual axons
and behavioral tests for motor function could reveal deficits in
older 4.1B mutants.
The juxtaparanode is established by interactions between
Caspr2 and TAG-1 (Poliak et al., 2003; Traka et al., 2003). In this
region, no axoglial junctions are formed, but a loose axoglial
scaffold is established that moves toward the paranode in paran-
odal mutants (Dupree et al., 1999; Bhat et al., 2001; Boyle et al.,
2001; Pillai et al., 2009). These findings suggest that the jux-
taparanode is not anchored with axonal cytoskeleton even
though Caspr2 also has 4.1B-binding sequences (Denisenko-
Nehrbass et al., 2003; Horresh et al., 2010). The juxtaparanodal
region clusters potassium channels, which are lost in Caspr2 and
Tag-1 mutants (Poliak et al., 2003; Traka et al., 2003). Interest-
ingly, both the -Act-Cre;4.1BFlox and 4.1B/ mutants revealed
disorganization of juxtaparanodal proteins, with loss of potas-
sium channels and Caspr2 localization (Figs. 2, 3) (data not
shown). This suggests that formation and/or stabilization of the
juxtaparanodal axoglial scaffold critically depends on 4.1B, thus
highlighting the role of axonal cytoskeletal adaptor proteins in
the stability of axonal domains.
Evolutionary role of cytoskeletal proteins in stabilizing
axoglial septate junctions
The founding member and Drosophila ortholog of the vertebrate
Caspr family, Neurexin IV (Nrx IV), contains a 4.1-binding se-
quence in its C-terminus (Baumgartner et al., 1996; Bellen et al.,
1998; Bhat, 2003, 2004; Banerjee et al., 2006a). An ortholog of the
vertebrate 4.1 family that colocalizes with Nrx IV at septate junc-
tions is Coracle (Cora) (Fehon et al., 1994). Null mutants of nrx
IV and cora show mislocalization of Cora and Nrx IV, respec-
tively, and fail to establish septate junctions (Fehon et al., 1994;
Baumgartner et al., 1996; Lamb et al., 1998; Ward et al., 1998;
Banerjee et al., 2006b). Furthermore, mutations in the FERM
domain of Cora disrupts its membrane localization, suggesting
that the interaction between Cora and its transmembrane-
binding partners is required for localization of Cora at the mem-
brane. Together, our data provide convincing evidence that 4.1B
is critically required for proper maintenance of axonal domains
in myelinated axons by acting as a molecular adaptor between
membrane components at the paranodal and juxtaparanodal re-
gions and the underlying axonal cytoskeleton. These interactions
are central to the long-term stability of axonal domains and thus
saltatory nerve conduction.
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